INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
98 hedge funds and large institutions have $51.6M invested in Insys Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 29 closing their positions.
Holders
98
Holders Change
-15
Holders Change %
-13.27%
% of All Funds
2.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
27
Reduced
18
Closed
29
Calls
$724K
Puts
$1.24M
Net Calls
-$517K
Net Calls Change
-$219K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$12.8M |
| 2 |
2
Renaissance Technologies
New York
|
$2.65M |
| 3 |
3
Millennium Management
New York
|
$3.75M |
| 4 |
PAM
4
Panagora Asset Management
Boston,
Massachusetts
|
$2.03M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$468K |
Top Sellers
| 1 |
EMG
1
ETF Managers Group
Summit,
New Jersey
|
$0 |
| 2 |
2
Norges Bank
Oslo,
Norway
|
$0 |
| 3 |
3
D.E. Shaw & Co
New York
|
$1.5M |
| 4 |
4
BlackRock
New York
|
$11.9M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$41K |